ELIZABETH PAPARODIS: Open Payments
NPI 1619682168 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 18 payments from 8 companies in 2025. Trend: 2023 $57 · 2024 $126 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $151 |
| Indivior Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $14 |
Products named: CAPLYTA, SUBLOCADE, REXULTI, VRAYLAR, Auvelity, UZEDY, FANAPT, ARISTADA.
Industry payments across OH — which companies pay providers there.
